ALB and nasopharyngeal carcinoma: In addition, the CRP/Alb ratio has showed promising prognostic value in gastric cancer [32], esophageal cancer [33], colorectal cancer [34], small cell lung cancer [35], and even in nonmetastatic NPC [36].